MERIT is a global clinical trial imaging endpoint services provider focusing on oncology studies. Our team are experts in managing and evaluating radiological images. MERIT’s knowledgeable clinical trial readers are board-certified to assure high-quality, consistent data review and interpretation.
MERIT provides imaging endpoint services in support of Phase I-IV clinical trials for innovative chemotherapies and immunotherapies in a variety of solid and liquid tumors. We have the flexibility and responsiveness to easily add modular services based on your trial needs. Our Collect and Hold service supports early-phase study image collection, quality control, cataloging, and storage in preparation for a potential read. This process can positively reduce start-up time for your projects. As your project progresses, MERIT can support additional capabilities including randomized reader and adjudication services. Contact us today to learn more about our Collect and Hold service.
We provide the same meticulous attention to detail for your clinical trial workflow whether you’re a biotech sponsor just launching your pipeline, or you’re an established pharmaceutical sponsor. Our refined and standardized processes from our global ophthalmology experience support efficiencies in our services across therapeutic areas. This often positively reduces overall costs and shortens timelines for our sponsors and partners.
Expert Readers for Clinical Trials
Our readers are board-certified radiologists experienced in performing radiology assessments for clinical trials in a variety of indications.
Response Criteria & Indication
Our readers are trained in response criteria, measurement requirements, and software functionality.
Custom Service Offerings
All readers will be trained for study-specific reading considerations according to each study charter and sponsor requirements.
MERIT provides added value to complex clinical trial projects through personalized service, deep scientific expertise, and exceptional quality. Our team includes:
Our team has extensive knowledge and experience in the imaging endpoint process standards of clinical trials. MERIT’s Quality Assurance team continuously monitors and maintains quality, providing crucial regulatory support through detailed SOPs and QA documentation. All MERIT staff are trained in GxP, human subject data protections, and GDPR readiness.
EXCELSIOR is the only integrated, market-leading platform designed for managing clinical trials that offers a clear advantage across image management, the read process, and response outcome reporting. Our all-in-one platform supports clinical trial management experts, site technicians, and readers, providing end-to-end processes with clean, complete, and accurate data to meet any clinical trial needs.
EXCELSIOR enables viewing DICOM images in split screen across study timepoints to measure and compare lesions qualitatively and quantitatively.
EXCELSIOR image viewer interactively records measurements, qualitative assessments, and anatomical location to generate calculated outcome/responses, comparing values across timepoints.
EXCELSIOR is a time-saving and validated image analysis platform. Our software platform offers many features that help support the read process to minimize the risk of bias and to provide accurate and robust endpoint data for your clinical trial.
A successful multi-center trial requires intrinsic understanding of various imaging techniques, developing meaningful outcome correlations, and formulating computational methodologies. Our insightful experts help guide your selection of the right biomarkers that accurately reflect the characteristics of disease progression and treatment effects.
Some companies tend to overpromise and underdeliver, which puts your study success at risk. If you’re looking for an oncology services provider that will value your partnership and make your study a priority, consider MERIT.